PEPG
PepGen (PEPG)
$52
About PepGen (PEPG)
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Details
Daily high
$5.69
Daily low
$5.35
Price at open
$5.47
52 Week High
$6.72
52 Week Low
$0.88
Market cap
379.5M
Dividend yield
0.00%
Volume
292,105
Avg. volume
766,149
P/E ratio
-1.95
PepGen News
Details
Daily high
$5.69
Daily low
$5.35
Price at open
$5.47
52 Week High
$6.72
52 Week Low
$0.88
Market cap
379.5M
Dividend yield
0.00%
Volume
292,105
Avg. volume
766,149
P/E ratio
-1.95